A federal judge in Indiana has pared back a consumer lawsuit accusing animal health company Elanco Animal Health Inc. of monopolizing the market for certain flea and tick treatments, according to Reuters. The case, which centers on allegations that the company’s business practices led to inflated prices for its Advantix line of products, will continue under state antitrust laws despite the dismissal of federal claims.
Featured News
States, Environmental Groups Oppose EPA Power-Plant Emissions Repeal
Oct 1, 2026 by
CPI
US Judge Dismisses Publisher Antitrust Cases Against Google Over AI Search
Oct 1, 2026 by
CPI
Mexico Antitrust Regulator Said to Clear $450 Million Telefónica Sale
Oct 1, 2026 by
CPI
Transocean’s $5.8 Billion Valaris Deal Clears U.S. Antitrust Review
Oct 1, 2026 by
CPI
Binance Faces EU Scrutiny Over Crypto Services Without MiCA License
Oct 1, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – National Security
Sep 22, 2026 by
CPI
National Security in U.S. Antitrust Enforcement: Toward a More Disciplined Framework
Sep 22, 2026 by
Rod Rosenstein & Timothy Finley
The Department of War’s M&A Review Guidance: What Companies in the Defense Industry Need to Know
Sep 22, 2026 by
Eric Stocking & Paul Ney
National Security, Resilience and the Boundaries of Merger Control
Sep 22, 2026 by
Beatriz Marques
National Security and Competition: Building Resilient Telecommunications Networks
Sep 22, 2026 by
Roslyn Layton